trial · primary record
Nab-paclitaxel
Pancreatic Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 112 |
| Primary completion | 2025-03-28 |
| Primary endpoint | Overall Survival |
| Registry ID | NCT05673811 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:16.080Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05673811
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.